Northwest Biotherapeutics (NWBO) Total Debt Growth (5y) (2015 - 2026)
Northwest Biotherapeutics (NWBO) Total Debt Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Northwest Biotherapeutics | 275.76 Mn | 273.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.18% |
| Dec 31, 2025 | 20.93% |
| Sep 30, 2025 | 0.93% |
| Jun 30, 2025 | 11.31% |
| Mar 31, 2025 | 19.90% |
| Dec 31, 2024 | 9.67% |
| Sep 30, 2024 | 33.12% |
| Jun 30, 2024 | 14.46% |
| Mar 31, 2024 | 37.01% |
| Dec 31, 2023 | 71.54% |
| Sep 30, 2023 | 29.96% |
| Jun 30, 2023 | 22.08% |
| Mar 31, 2023 | 15.46% |
| Dec 31, 2022 | 33.61% |
| Sep 30, 2022 | -14.76% |
| Jun 30, 2022 | 31.50% |
| Mar 31, 2022 | 13.35% |
| Dec 31, 2021 | 32.42% |
| Sep 30, 2021 | 14.98% |
| Jun 30, 2021 | 14.86% |